Columbia Trust CO 01012016 Eli Lilly & CO Transaction History

Columbia Trust CO 01012016

$220 Million
Q4 2023

A detailed history of Columbia Trust CO 01012016 transactions in Eli Lilly & CO stock. As of the latest transaction made, Columbia Trust CO 01012016 holds 1,056 shares of LLY stock, worth $789,898. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,056

Previous 1,017 3.83%

Holding current value

$789,898

Previous $546,000 12.64%

% of portfolio

0.28%

Previous 0.32%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$525.19 - $619.13 $20,482 - $24,146	39 Added 3.83%	1,056 $615,000
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $1,738 - $2,397	4 Added 0.39%	1,017 $546,000
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $8,768 - $11,724	-25 Reduced 2.41%	1,013 $475,000
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $2,174 - $2,553	7 Added 0.68%	1,038 $356,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $17,685 - $20,606	-55 Reduced 5.06%	1,031 $377,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $61,320 - $71,999	-220 Reduced 16.85%	1,086 $352,000
Q1 2022 Apr 15, 2022	SELL	$234.69 - $291.66 $6,571 - $8,166	-28 Reduced 2.1%	1,306 $394,000
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $33,240 - $40,906	150 Added 12.67%	1,334 $308,000
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $213,771 - $276,511	1,184 New	1,184 $272,000
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $196,081 - $259,462	-1,503 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $123,596 - $148,747	-906 Reduced 37.61%	1,503 $246,000
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $2,142 - $2,652	18 Added 0.75%	2,409 $333,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $255,645 - $316,640	2,391 New	2,391 $314,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Trust CO 01012016, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Trust CO 01012016 with notifications on news.

Account

Columbia Trust CO 01012016 Eli Lilly & CO Transaction History